Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Endothelial vascular toxicity from chemotherapeutic agents: Preclinical evidence and clinical implications — Aspasia Soultati (2011) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Endothelial vascular toxicity from chemotherapeutic agents: Preclinical evidence and clinical implications
Shared by
Meletios A Dimopoulos
Endothelial vascular toxicity from chemotherapeutic agents: Preclinical evidence and clinical implications
Article
2011
en
Authors
+4 more
AS
Aspasia Soultati
GM
Giannis Mountzios
CA
Chrysoula Avgerinou
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2004
New Anti-HIV Agents in Preclinical or Clinical Development
De Clercq Erik
Article
2005
Pulmonary toxicity from novel antineoplastic agents
Ioanna Dimopoulou
,
Aristotle Bamias
,
Panagiotis Lyberopoulos
,
Meletios A Dimopoulos
Article
2021
Multi‐Mechanistic Antidiabetic Potential of Astaxanthin: An Update on Preclinical and Clinical Evidence
Vemana Gowd
,
Jianbo Xiao
,
Mingfu Wang
,
Feng Chen
,
Ka‐Wing Cheng
Article
1999
Role of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptors in Vascular Development
Peter Carmeliet
,
Désiré Collen
Article
1999
Gene transfer of vascular endothelial growth factor and endothelial nitric oxide synthase--implications for gene therapy in cardiovascular diseases.
Jozef Dulak
,
A Józkowicz
,
I Guevara
,
A. Dembińska-Kieć
Discussion(0)
No comments yet. Be the first to comment.